Trulieve Cannabis Corp, founded in 2015 and headquartered in Tallahassee, Florida, is a leading provider of cannabis products in the United States, focusing on enhancing the quality of life for its customers through a patient-centered approach. The company offers a comprehensive range of products, including medical and recreational cannabis offerings, concentrates, edibles, and wellness products, catering to both medical patients and adult consumers.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| TRULCN 8.00% 2026-10-06 USDTrulieve Cannabis Corp | United States | 2026-10-06 | 8.000 | 9.24 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Trulieve began issuing bonds in 2020 to support its expansion efforts and operational growth. One notable issuance was a $100 million senior secured note, which aimed to finance new dispensaries and cultivation facilities. As of 2023, the yield on Trulieve’s bonds has been competitive within the cannabis industry, reflecting both the company’s robust growth strategy and market conditions. Recent developments, such as strategic acquisitions and expansions, have bolstered investor interest, adding to the appeal of its bonds amid a growing market environment.